HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$3.60
Day range
$3.54 - $3.79
Year range
$3.00 - $5.48
Market cap
116.20M CAD
Avg Volume
12.64K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 14.52M | -11.56% |
Operating expense | 12.82M | -20.86% |
Net income | -5.68M | 39.79% |
Net profit margin | -39.13 | 31.92% |
Earnings per share | -0.29 | -65.89% |
EBITDA | 3.83M | -28.63% |
Effective tax rate | -253.80% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.52M | 55.34% |
Total assets | 191.32M | -15.65% |
Total liabilities | 108.62M | -5.86% |
Total equity | 82.71M | — |
Shares outstanding | 31.79M | — |
Price to book | 1.38 | — |
Return on assets | -2.60% | — |
Return on capital | -2.98% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -5.68M | 39.79% |
Cash from operations | 2.52M | -5.58% |
Cash from investing | 13.25M | 9,914.81% |
Cash from financing | -2.58M | 12.48% |
Net change in cash | 13.07M | 4,735.46% |
Free cash flow | 4.27M | -26.43% |
About
Founded
2014
Website
Employees
91
